Ablation technologies of different types have in common their ability to produce a therapeutic effect on human tissue. Beyond this common ground, however, there are stark differences in the modalities. Consequently, ablation technologies have variable penetration of clinical applications, with use of specific modalities for specific clinical applications driven by factors such as the tissue effect produced, likelihood of collateral tissue damage, the designs of manufacturers’ specific systems in meeting clinicians needs, cost, and other considerations.
Cancer treatment is a good example, with a few modalities having significant shares of their worldwide ablation revenuesin cancer, while other modalities are little used in these areas.
Source: MedMarket Diligence, LLC; Report #A125, "Worldwide Ablation Technologies."